A detailed history of Golden State Wealth Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 44 shares of CRL stock, worth $7,285. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44
Holding current value
$7,285
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$178.58 - $220.69 $7,857 - $9,710
44 New
44 $8.12 Million
Q2 2020

Aug 11, 2020

SELL
$118.84 - $189.72 $1,782 - $2,845
-15 Closed
0 $0
Q1 2020

Apr 17, 2020

BUY
$98.9 - $178.34 $1,483 - $2,675
15 New
15 $2,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.42B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Golden State Wealth Management, LLC Portfolio

Follow Golden State Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Wealth Management, LLC with notifications on news.